The Society for Immunotherapy of Cancer (SITC) joined more than 50 organizations through One Voice Against Cancer (OVAC) in signing a coalition letter to Congress raising concerns about delays and disruptions in federal cancer research funding. View the letter in its entirety at this LINK . ...
SITC Announces Keynote Speakers Dr. Ton Schumacher and Dr. Catherine J. Wu at its 41 st Annual Meeting The largest cancer immunotherapy conference featuring the latest research in immuno-oncology MILWAUKEE, WI – The Society for Immunotherapy of Cancer (SITC) is proud to announce...
INSIDE THIS ISSUE: Letter from the Editor| JITC Editor Picks| JITC Meet-the-Editor Session at ASCO| Popular Articles Letter from the Editor Hello JITC Readers, This last month on April 29 th we celebrated with the International Union...
A Message from the President Staying current in immuno-oncology has never been more important—or more complex. With rapid advances across research, clinical practice, and regulation, access to timely, trusted education is essential. That’s where our brand-new Society for Immunotherapy of...
As Congress begins deliberations on Fiscal Year 2027 (FY27) appropriations, continued investment in the National Institutes of Health (NIH) remains essential to sustaining progress in biomedical research and innovation. The Society for Immunotherapy of Cancer (SITC) is proud to join a...
We’re excited to announce that The CheckPoints, SITC’s house band, will return to Buddy Guy’s Legends in Chicago (700 S. Wabash Ave.) on May 31, 2026 ! The CheckPoints consists of SITC members who are known for both their musical talent and as luminaries in the field of cancer...
05-31-2026 | 20:00 - 23:59 CT Chicago IL
The SITC Sparkathon – Emerging Leaders, Igniting Innovation is an exciting opportunity for early career professionals seeking to participate in new research that contributes to the cancer immunotherapy field and the Society for Immunotherapy of Cancer. WIN Main Page Program Details SITC...
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 AACR Annual Meeting, April 17–22, 2026. (Thanks to Jennifer Anderson, MD, PhD and Terri Holzen, PhD for compiling these scientific highlights) Phase 1 study of GV20-0251, a human...